Navigation Links
Scientists discover who is likely to get dry eye syndrome after LASIK surgery
Date:3/3/2008

Boston, MAScientists at Schepens Eye Research Institute have found that people with a certain low level of tear production are more likely to develop chronic dry eye syndrome after LASIK (laser-assisted in situ keratomileusis), laser refractive surgery to correct near- and far-sightedness than those with more plentiful tears. Their research, published in the January issue of Investigative Ophthalmology and Vision Science, may offer reliable prescreening criteria for ophthalmologists and patients.

These findings should help ophthalmologists determine if pretreatment is necessary before surgery or if surgery is appropriate at all for an individual, says Dr. Darlene Dartt, director of the Military Vision Research Program at Schepens Eye Research Institute and the principal investigator of the study.

Dry eye syndrome is one of the most common problems treated by eye physicians. Affecting more than 10 million Americans, it is caused by problems with the tear film responsible for lubricating the eye. While it does not cause vision loss, dry eye syndrome can be painful and severely decrease quality of life for its victims who constantly search for relief with artificial tears and other medications.

LASIK surgery uses small laser cuts to reshape the surface of the cornea, eliminating far-sightedness or near-sightedness, and the need for glasses or contacts. Many people choose LASIK for cosmetic reasons. In recent years, thousands of military personnel have opted for LASIK surgery because it can help them see better and identify objects and people in the field more quickly. It also relieves them of the worry about lost or damaged glasses.

Usually, LASIK causes some dry eye syndrome directly after surgery, but the condition resolves within a few months. In a small number of cases, however, the dry eye condition following LASIK can become chronic and impact functioning of both civilian and military individuals for as long as nine months following surgery.

Dartt and her team were determined to find a way to prescreen for the chronic condition so that surgeons could prepare patients in advance with preventative artificial tears or opt against surgery for some patients.

Dartt and her team evaluated the eyes of 24 patients about to undergo LASIK at the Massachusetts Eye and Ear Infirmary. The patients were given a series of evaluations, including the Schirmer test with and without anesthesia, before and after surgery. Using a piece of paper on the corneal surface, the Schirmer test measures the amount of tears an eye is producing. Study subjects also filled out a dry eye questionnaire indicating their experience with dry eyes pre- and post-operatively.

The team discovered that if a patient had a presurgical tear production value greater than 20 mm of wetting of the Schrimer strip in 5 minutes, they were not likely to develop chronic dry eye syndrome. Patients who produced less tears were more likely to develop long-term dry eye syndrome.

According to Dartt, the next steps for her team include expanding this study to a larger number of individuals and examining patients who have the PRK (photorefractive keratectomy) type of refractive surgery. The PRK has the same goal as LASIK, but the procedures differ. In LASIK a flap of corneal epithelium is cut and lifted to allow the underlying stroma to be shaped by the laser. Then the flap is placed down on the eye. In PRK the corneal epithelium is mechanically removed to allow laser shaping of the stroma. The epithelium then grows back over several days. LASIK and PRK have different side effects.


'/>"/>

Contact: Patti Jacobs
pjacobs12@comcast.net
617-868-0077
Schepens Eye Research Institute
Source:Eurekalert

Related medicine news :

1. Scientists uncover further steps leading to celiac disease
2. Scientists Find Cancer Culprits in Cigarette Smoke
3. Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
4. Scripps research scientists devise approach that stops HIV at earliest stage of infection
5. Scientists look at syringe assembly in plague bacteria
6. Scientists identify proteins that help bacteria put up a fight
7. CSHL scientists discover new details of a gene-regulatory network governing metabolism
8. Scientists make first map of emerging-disease hotpsots
9. Scientists shed light on long-distance signaling in developing neurons
10. Scientists explore consciousness
11. Scientists using laser light to detect potential diseases via breath samples, says new study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier ... professionals caring for those suffering from the full spectrum of disordered eating, announced today ... disorders professionals from nearly all 50 states and several countries converged on the Green ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... its innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the ... product – with nearly 2,000 consumers (and counting) already backing the campaign. ...
(Date:3/24/2017)... Oakland, CA (PRWEB) , ... March 24, 2017 ... ... present on two panels at the Advanced ERISA Benefit Claims Litigation seminar in ... and Creating the Administrative Record, The majority of cases litigated under ERISA involve ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... to Walk with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward ... Learning How to Walk with God #TruthwithGrace” is the creation of published author ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has announced ... 2016" report to their offering. ... The IPF pipeline is very strong with a total of ... Co., Inc., Biogen and Sanofi are involved in the development of the ... one is in Phase III stage, 15 are in Phase II stage, ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: